(DCI) Donaldson - Ratings and Ratios
Filters, Collectors, Purifiers, Bioprocessing, Membranes
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 1.27% |
| Yield on Cost 5y | 2.13% |
| Yield CAGR 5y | 7.69% |
| Payout Consistency | 99.5% |
| Payout Ratio | 30.9% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 20.4% |
| Value at Risk 5%th | 31.5% |
| Relative Tail Risk | -6.21% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 1.24 |
| Alpha | 21.63 |
| CAGR/Max DD | 0.71 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.274 |
| Beta | 0.856 |
| Beta Downside | 0.766 |
| Drawdowns 3y | |
|---|---|
| Max DD | 23.81% |
| Mean DD | 5.48% |
| Median DD | 4.47% |
Description: DCI Donaldson January 06, 2026
Donaldson Company Inc. (NYSE: DCI) designs, manufactures, and distributes filtration systems and replacement parts across three operating segments: Mobile Solutions, Industrial Solutions, and Life Sciences. The Mobile Solutions segment supplies air- and liquid-filtration components-such as fuel, lube, hydraulic, and emissions filters-to OEMs in construction, mining, agriculture, and transportation, as well as to independent distributors and dealer networks. The Industrial Solutions segment covers dust, fume, and mist collectors; compressed-air and gas-purification units; power-generation inlet systems; and aerospace/defense filtration for aircraft, ground-vehicle, and naval platforms. The Life Sciences segment provides micro-environment gas and liquid filtration for food-beverage, bioprocessing (bioreactors, fermenters, chromatography consumables), and high-purity applications in semiconductors, hard-disk drives, battery systems, and powertrain components.
Key performance indicators from the most recent fiscal year (2023) show total revenue of roughly $2.5 billion, an operating margin of ≈ 12 %, and a backlog of about $1.1 billion, indicating solid demand visibility. The company’s growth is tied to macro-drivers such as the global shift toward electric vehicles (which raises demand for high-efficiency coolant and battery filtration), expanding renewable-energy generation (requiring robust air-inlet and gas-purification for turbines), and continued expansion of biopharma manufacturing capacity, which fuels the Life Sciences segment.
Analysts should watch the OEM cycle in the construction and mining sectors-where a slowdown could compress Mobile Solutions sales-and monitor the pace of EV adoption, as higher-volume battery packs increase the need for specialized filtration. Additionally, the aerospace-defense market’s fiscal-year spending trends can materially affect the Industrial Solutions segment’s top line. For a deeper dive into DCI’s valuation metrics, the ValueRay platform offers a concise, data-rich overview.
Piotroski VR‑10 (Strict, 0-10) 8.0
| Net Income (381.9m TTM) > 0 and > 6% of Revenue (6% = 223.6m TTM) |
| FCFTA 0.13 (>2.0%) and ΔFCFTA 2.15pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 21.75% (prev 18.65%; Δ 3.10pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.16 (>3.0%) and CFO 471.3m > Net Income 381.9m (YES >=105%, WARN >=100%) |
| Net Debt (463.3m) to EBITDA (633.3m) ratio: 0.73 <= 3.0 (WARN <= 3.5) |
| Current Ratio 2.15 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (117.8m) change vs 12m ago -3.36% (target <= -2.0% for YES) |
| Gross Margin 34.76% (prev 35.31%; Δ -0.55pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 122.8% (prev 119.6%; Δ 3.17pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 20.74 (EBITDA TTM 633.3m / Interest Expense TTM 25.8m) >= 6 (WARN >= 3) |
Altman Z'' 8.18
| (A) 0.27 = (Total Current Assets 1.51b - Total Current Liabilities 703.9m) / Total Assets 3.03b |
| (B) 0.90 = Retained Earnings (Balance) 2.72b / Total Assets 3.03b |
| warn (B) unusual magnitude: 0.90 — check mapping/units |
| (C) 0.18 = EBIT TTM 535.0m / Avg Total Assets 3.04b |
| (D) 2.19 = Book Value of Equity 3.31b / Total Liabilities 1.51b |
| Total Rating: 8.18 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 86.91
| 1. Piotroski 8.0pt |
| 2. FCF Yield 3.71% |
| 3. FCF Margin 10.82% |
| 4. Debt/Equity 0.44 |
| 5. Debt/Ebitda 0.73 |
| 6. ROIC - WACC (= 10.49)% |
| 7. RoE 25.55% |
| 8. Rev. Trend 79.58% |
| 9. EPS Trend 84.97% |
What is the price of DCI shares?
Over the past week, the price has changed by +2.07%, over one month by +0.44%, over three months by +11.38% and over the past year by +38.54%.
Is DCI a buy, sell or hold?
- Strong Buy: 1
- Buy: 0
- Hold: 6
- Sell: 0
- Strong Sell: 1
What are the forecasts/targets for the DCI price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 91.6 | -0.6% |
| Analysts Target Price | 91.6 | -0.6% |
| ValueRay Target Price | 109.6 | 19% |
DCI Fundamental Data Overview January 05, 2026
P/E Trailing = 28.0156
P/E Forward = 22.3214
P/S = 2.7955
P/B = 6.8391
P/EG = 2.022
Beta = 0.994
Revenue TTM = 3.73b USD
EBIT TTM = 535.0m USD
EBITDA TTM = 633.3m USD
Long Term Debt = 671.5m USD (from longTermDebt, last quarter)
Short Term Debt = 2.50m USD (from shortTermDebt, last quarter)
Debt = 674.0m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 463.3m USD (from netDebt column, last quarter)
Enterprise Value = 10.88b USD (10.42b + Debt 674.0m - CCE 210.7m)
Interest Coverage Ratio = 20.74 (Ebit TTM 535.0m / Interest Expense TTM 25.8m)
FCF Yield = 3.71% (FCF TTM 403.2m / Enterprise Value 10.88b)
FCF Margin = 10.82% (FCF TTM 403.2m / Revenue TTM 3.73b)
Net Margin = 10.25% (Net Income TTM 381.9m / Revenue TTM 3.73b)
Gross Margin = 34.76% ((Revenue TTM 3.73b - Cost of Revenue TTM 2.43b) / Revenue TTM)
Gross Margin QoQ = 35.15% (prev 34.55%)
Tobins Q-Ratio = 3.59 (Enterprise Value 10.88b / Total Assets 3.03b)
Interest Expense / Debt = 1.05% (Interest Expense 7.10m / Debt 674.0m)
Taxrate = 22.78% (33.6m / 147.5m)
NOPAT = 413.1m (EBIT 535.0m * (1 - 22.78%))
Current Ratio = 2.15 (Total Current Assets 1.51b / Total Current Liabilities 703.9m)
Debt / Equity = 0.44 (Debt 674.0m / totalStockholderEquity, last quarter 1.52b)
Debt / EBITDA = 0.73 (Net Debt 463.3m / EBITDA 633.3m)
Debt / FCF = 1.15 (Net Debt 463.3m / FCF TTM 403.2m)
Total Stockholder Equity = 1.49b (last 4 quarters mean from totalStockholderEquity)
RoA = 12.62% (Net Income 381.9m / Total Assets 3.03b)
RoE = 25.55% (Net Income TTM 381.9m / Total Stockholder Equity 1.49b)
RoCE = 24.70% (EBIT 535.0m / Capital Employed (Equity 1.49b + L.T.Debt 671.5m))
RoIC = 19.15% (NOPAT 413.1m / Invested Capital 2.16b)
WACC = 8.66% (E(10.42b)/V(11.09b) * Re(9.17%) + D(674.0m)/V(11.09b) * Rd(1.05%) * (1-Tc(0.23)))
Discount Rate = 9.17% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.98%
[DCF Debug] Terminal Value 77.81% ; FCFE base≈377.9m ; Y1≈464.5m ; Y5≈785.7m
Fair Price DCF = 94.25 (DCF Value 10.87b / Shares Outstanding 115.3m; 5y FCF grow 24.50% → 3.0% )
EPS Correlation: 84.97 | EPS CAGR: 14.27% | SUE: 0.60 | # QB: 0
Revenue Correlation: 79.58 | Revenue CAGR: 4.17% | SUE: 0.64 | # QB: 0
EPS next Quarter (2026-04-30): EPS=1.06 | Chg30d=+0.012 | Revisions Net=+4 | Analysts=6
EPS current Year (2026-07-31): EPS=4.04 | Chg30d=+0.027 | Revisions Net=+7 | Growth EPS=+9.8% | Growth Revenue=+3.6%
EPS next Year (2027-07-31): EPS=4.42 | Chg30d=+0.062 | Revisions Net=+6 | Growth EPS=+9.4% | Growth Revenue=+4.6%
Additional Sources for DCI Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle